← Toutes les leçons

Leçon d'actualité · 2026-11-11

QuizJet · Niveau: B1

QuizJet rédige lui-même ces textes à partir d'articles de presse publics et met les liens des articles sous chaque texte.

Touche un mot pour voir son sens. ▶ lit le texte à voix haute et surligne la phrase en cours.

Politique: China extends a temporary trade truce with the United States.

China has suspended an additional 24% tariff on imports from the United States for two months. However, a 10% Chinese tariff on US goods will remain in place. The suspension will continue until January 10, 2027.

China has also suspended special port fees on ships linked to the United States. In addition, Beijing has extended sanctions relief for five US-linked units of Hanwha Ocean. These steps follow the trade agreement reached by Trump and Xi in September.

The temporary truce lowers the immediate risk that import prices will rise because of new tariffs. It also gives businesses more time to prepare before tariffs could increase again. Companies that trade between the two countries may welcome the extra time, but the future rules are still not certain.

The measures come as Chinese trade continues to grow. China's exports rose by 35% year-on-year in October. Its trade surplus was more than $1 trillion for the second year in a row. Chinese exports to the United States also increased by 32.9% in October.

Further negotiations between China and the United States will decide whether the temporary truce becomes permanent. Until then, some tariffs remain, while the additional tariff and other measures are paused. The final result will be important for businesses that depend on trade between the two countries.

Rédigé à partir de ces articles: China extends suspension of 24% tariff on US imports for two months · China's trade surplus surpasses $1 trillion for a 2nd straight year, as exports surge 35%

Économie: US stocks ended lower on November 10.

The main US stock indexes, which measure groups of major shares, fell on November 10. The S&P 500 lost 0.4% and closed at 7,520.93. The Nasdaq dropped 0.7% to 25,065.87, while the Dow Jones declined 0.3% to 52,231.89. Technology was the weakest sector, or business group, with a fall of 1.4%. Financials led the market with a gain of 0.5%. However, the indexes still had weekly gains through November 10. The S&P 500 and Nasdaq were both up 2% for the week, and the Dow was up 1.8%.

Inflation and interest-rate expectations were important market drivers. The Consumer Price Index, or CPI, measures changes in consumer prices. October CPI rose 0.4% from the previous month. Core CPI, which leaves out some prices that often change quickly, increased 0.3%. The odds of a Federal Reserve rate increase in December climbed from 80% to 98%. Treasury yields, which show the return on US government debt, also rose. The two-year yield moved from 4.60% to 4.69%, while the ten-year yield increased from 4.89% to 4.95%. Separately, payrolls, meaning the number of jobs reported by employers, grew by 165,000 in October. Unemployment stayed at 4.1%.

In markets connected with geopolitical risk, Brent crude, an international oil price, fell 2.6% to about $90.10 on November 10. Gold also declined. It lost 1.5% and finished at $4,078 per ounce, a standard measure of weight for gold. Both moves were larger than the percentage declines in the three main US stock indexes.

Measures of risk appetite and fear were mixed but generally weaker. Risk appetite means investors' willingness to hold assets whose prices can change sharply. The VIX, an index that measures expected stock-market changes and is often used as a fear measure, rose 0.2 points to 20.1. Bitcoin, a digital asset, fell 0.9% to about $74,242. These moves came as all three major stock indexes declined.

The next day, November 11, has no major US economic release scheduled. On November 12, investors will receive jobless claims, which count new requests for unemployment support, and existing-home sales. Federal Reserve speakers are also scheduled. November 13 will bring October's Producer Price Index, or PPI, which measures price changes for producers. Core PPI and manufacturing sales are also due that day. These reports may give the market more information about prices, jobs, housing, and business activity.

Overall, higher interest-rate expectations appear to have moved the stock market most on November 10. This view is supported by the rise in December Fed-hike odds from 80% to 98% and by higher two-year and ten-year Treasury yields after the CPI data. Technology fell more than the wider market, helping explain the Nasdaq's larger decline. Oil, gold, Bitcoin, and the VIX also showed caution, but the direct combination of inflation data, rate expectations, and rising yields gives the strongest explanation for the day's stock losses. Even so, the indexes remained higher for the week.

Rédigé à partir de ces articles: How major US stock indexes fared Tuesday 11/10/2026 · Trading Day: US rate outlook trumps everything · Global Markets Monitor November 10, 2026 · AI stocks bounce back — with one notable exception · Nvidia and Jensen Huang face shareholder lawsuit alleging investors were misled · The Magnificent Seven's Market Cap vs. the S&P 500 · Nvidia leads megacap slide as Amazon gains modestly

Sport: The 2027 Asian Cup has been postponed

The Asian Football Confederation has postponed the 2027 Asian Cup in Saudi Arabia. Regional conflict has created problems with security, travel and tournament organization. The event is Asian football's main championship for national teams.

The tournament was originally planned from January 7 to February 5, 2027. Under the new schedule, it will take place from December 23, 2027, to January 21, 2028. This means the competition will begin nearly one year later than first planned. However, FIFA must approve the revised dates before they become official.

Twenty-four national teams are expected to compete in the tournament. Matches are planned in three Saudi Arabian cities: Riyadh, Jeddah and Khobar. The new dates give organizers more time to deal with the security, travel and logistical problems caused by the regional conflict.

The postponement will also affect national-team coaches. They must change their plans for preparing players and organizing team activities. Player-release planning may also become more difficult because clubs need to know when their players will leave for international duty. Coaches, clubs and football organizations will now have to prepare for a tournament that crosses from the end of 2027 into the start of 2028.

Rédigé à partir de ces articles: Houthi Missiles Force Postponement of Saudi Asian Cup · GULF TIMES SPORT

Science: The FDA approves Sunharbo for some stroke patients.

The U.S. Food and Drug Administration approved Sunharbo on November 9, 2026. Sunharbo is Bayer's asundexian blood-thinning medicine. It works by targeting Factor XIa, a protein that helps blood to clot. The medicine is designed to lower the risk of another stroke in certain patients.

The approval covers adults who have had certain ischemic strokes. This type of stroke happens when a blood clot blocks the flow of blood to the brain. The approval also includes adults who have had high-risk transient ischemic attacks. These attacks are sometimes described as short warning signs of a possible stroke.

Patients must take Sunharbo together with antiplatelet treatment. Antiplatelet medicines help stop blood cells called platelets from sticking together and forming clots. A trial involving 12,327 people found that patients taking Sunharbo had 26% fewer ischemic strokes.

Overall, the rates of major bleeding were similar between the groups in the trial. However, bleeding increased among patients who were older than 75. This finding may be important when doctors consider treatment for older adults.

Sunharbo is not approved to prevent strokes caused by atrial fibrillation, a condition that causes an irregular heartbeat. The medicine is expected to become available in the United States in mid-to-late November 2026.

Rédigé à partir de ces articles: US FDA approves Bayer's blood thinner to prevent repeat strokes · FDA approves novel Bayer drug to reduce recurrence of stroke · FDA Approves First Factor XIa Inhibitor to Help Prevent Stroke in Certain Adults at High Risk

0 / 0

Réglages de lecture

Les voix viennent de ton appareil. Les plus naturelles ont Natural, Enhanced ou Premium dans leur nom ; tu peux les télécharger dans les réglages vocaux de ton appareil. Sur ordinateur, Microsoft Edge les intègre déjà.

Taille du texte
Interligne
Thème
Affichage

Mes mots

    Aucun mot enregistré pour l'instant. Touche un mot dans le texte et enregistre-le.